Live Breaking News & Updates on Harlan Bioproducts

The current opioid epidemic warrants a better understanding of genetic and environmental factors that contribute to opioid addiction. Here we report an increased prevalence of vitamin D (VitD) deficiency in patients diagnosed with opioid use disorder and an inverse and dose-dependent association of VitD levels with self-reported opioid use. We used multiple pharmacologic approaches and genetic mouse models and found that deficiencies in VitD signaling amplify exogenous opioid responses that are normalized upon restoration of VitD signaling. Similarly, physiologic endogenous opioid analgesia and reward responses triggered by ultraviolet (UV) radiation are repressed by VitD signaling, suggesting that a feedback loop exists whereby VitD deficiency produces increased UV/endorphin-seeking behavior until VitD levels are restored by cutaneous VitD synthesis. This feedback may carry the evolutionary advantage of maximizing VitD synthesis. However, unlike UV exposure, exogenous opioid use is no ....

United States , Santa Clara , Allen Brian Atlas , National Health , Sheldong Adelson Medical Research Foundation , John Wayne Cancer Institute Sequencing Center , Rosztoczy Foundation Scholarship Program , National Survey On Drug , Laboratories Inc , Soltego Inc , Research Diets Inc , Nutrition Examination , Committee At Massachusetts , National Survey , Drug Use , Nutrition Examination Survey , Massachusetts General Hospital , Some Vitd Deficient , Dietary Vitd , Rescuing Vitd , New Brunswick , Harlan Bioproducts , Institutional Animal Care , Use Committee , Massachusetts General , Inhibitory Units ,